Replicate Bioscience develops self-replicating RNA therapeutics and vaccines delivering immunity at lower doses across multiple diseases.
Replicate Bioscience has raised $3.0M in total funding. The most recent round was Grant. The last funding was announced in June 2026.
Replicate Bioscience's investors include Bill & Melinda Gates Foundation, Apple Tree Partners.
Replicate Bioscience is headquartered in San Diego, United States.
Replicate Bioscience develops self-replicating RNA therapeutics and vaccines delivering immunity at lower doses across multiple diseases.
Replicate Bioscience is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Replicate Bioscience — Funding & Investors." VCBacked, June 19, 2026, https://www.vcbacked.co/company/replicate-bioscience. Accessed August 13, 2026.
VCBacked. (2026). Replicate Bioscience — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/replicate-bioscience
{{cite web |title=Replicate Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/replicate-bioscience |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated